C. difficile and Shock

Summary:

Shock is found among people with C. difficile, especially for people who are female, 50-59 old.

The study analyzes which people have Shock with C. difficile. It is created by eHealthMe based on reports of 11 people who have C. difficile from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is C. difficile?

C. difficile is found to be associated with 1,815 drugs and 1,784 conditions by eHealthMe. Check the latest studies of C. difficile.

What is Shock?

Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin) is found to be associated with 1,223 drugs and 1,753 conditions by eHealthMe. Check the latest studies of Shock.



On Jun, 18, 2026

11 people who have C. Difficile and Shock are studied.

Would you have Shock when you have C. difficile?

Gender of people who have C. Difficile and experienced Shock *:

  • female: 90 %
  • male: 10 %

Age of people who have C. Difficile and experienced Shock *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 22.22 %
  • 50-59: 55.56 %
  • 60+: 22.22 %

Common co-existing conditions for these people *:

  1. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 36.36%
  2. Cytomegalovirus Colitis (an inflammation of the colon from virus): 4 people, 36.36%
  3. Platelet Disorder: 4 people, 36.36%
  4. Oral Candidiasis (fungal infection of mouth): 4 people, 36.36%
  5. Indigestion: 4 people, 36.36%
  6. Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 36.36%
  7. Hiv Infection: 4 people, 36.36%
  8. Haemoglobin Abnormal: 4 people, 36.36%
  9. Gastric Ulcer (stomach ulcer): 4 people, 36.36%
  10. Blood Magnesium Decreased: 3 people, 27.27%

Common drugs taken by these people *:

  1. Vancomycin: 6 people, 54.55%
  2. Meropenem: 6 people, 54.55%
  3. Zithromax: 4 people, 36.36%
  4. Raltegravir: 4 people, 36.36%
  5. Actonel: 4 people, 36.36%
  6. Aloxi: 4 people, 36.36%
  7. Centrum: 4 people, 36.36%
  8. Emend: 4 people, 36.36%
  9. Abacavir: 4 people, 36.36%
  10. Thiamine Hcl: 4 people, 36.36%

Common symptoms for these people *:

  1. Diarrhea: 4 people, 36.36%
  2. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 4 people, 36.36%
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 36.36%
  4. Urinary Tract Infection: 4 people, 36.36%
  5. Anaemia (lack of blood): 4 people, 36.36%
  6. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 4 people, 36.36%
  7. Pneumonia Fungal: 4 people, 36.36%
  8. Osteoporosis (bones weak and more likely to break): 4 people, 36.36%
  9. Depressed Mood: 4 people, 36.36%
  10. Hyperbilirubinaemia (excess of bilirubin in the blood): 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Shock?

- Check whether Shock is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Shock:

All the conditions that are associated with Shock:

  • Shock (1,753 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Shock and C. difficile, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: